Posts Tagged ‘OPAM’

Coming Changes to NIH Clinical Trials and How They Affect Your Research

Beginning in 2018, NIH is changing the definition of a clinical trial—expanding it beyond its current scope. If you work with human subjects, your research may be affected, including the indirect cost rates you can put on your grants. But not all NIH institutes are following the same guidelines. You’re invited to hear the latest on these changes and what they may mean for you from our experts in OPAM. Session 1 Date: Thursday, December … Read More

Updated pre-award service level understanding agreement in effect Oct. 6

It’s not novel. It’s not new. It’s just improved! The Office of Proposal and Award Management, with assistance from departmental representatives across OHSU, have arrived at an updated service level understanding (SLU) agreement. The updated SLU will go into effect Oct. 6, 2015. The purposes of the SLU are to: Describe the pre-award services to be provided by OPAM to research departments and units at OHSU Identify the performance expectations for the pre-award services offered … Read More

InfoEd and OGA classes offered Jan. 14

  Research Administration Training & Education (RATE) offers a number of courses for the OHSU research community. On the calendar for next week: OGA and InfoEd. InfoEd InfoEd’s Proposal Development module is required for preparing and submissions that go through the Office of Proposal and Award Management (OPAM). The electronic Proposed Project Questionnaire (ePPQ) is completed within InfoEd for both and submissions. Walk step-by-step through the process of creating and routing an … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.